/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_oncology_headshot_david_cutter.png

Dr David Cutter

Dr David Cutter
David
Cutter
MBBChir, MRCP, FRCR, DPhil, Clinical oncologist

Languages spoken

English

Expert in

Blood cancer

Overview

Centers

Oxford
Oxford

Peters Way, Sandy Lane West, Oxford, OX4 6LB

51.7239071200697, -1.2145938932540707
/uk/our-centres/oxford
+44 (0)1865 237 700
mediahawkNumber3680 mhMobile

Specialises in

Blood cancer
Condition
Condition/Cancer
Condition/Cancer/Blood cancer

Treatments

Deep Inspiration Breath Hold
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Deep inspiration breath hold
External beam radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/External beam radiotherapy
Intensity modulated radiotherapy (IMRT)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Intensity modulated radiotherapy
Palliative radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Palliative radiotherapy
Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Radiotherapy

Dr David Cutter is a recognised Clinical Oncologist based in Oxford and specialises in radiotherapy for Haematological Malignancies. Dr Cutter studied at the University of Cambridge and trained in Oncology at the Oxford Cancer Centre. He is currently a Consultant Clinical Oncologist and Senior Clinical Research Fellow at the University of Oxford.

Careerpositions

Career positions

Current position(s)

  • Consultant Clinical Oncologist, Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust

Education

Universities

  • University of Cambridge and trained in Oncology at the Oxford Cancer Centre
  • Senior Clinical Research Fellow at the University of Oxford

 

Expertise and interests

Expertise

Interests

  • Blood cancer
  • Radiotherapy for haematological malignancies

Professional memberships

  • Royal College of Radiologists
  • Royal College of Physicians
  • National Cancer Research Institute Lymphoma Research Group (and Hodgkin lymphoma sub-group)
  • UK Lymphoma Radiotherapy Group (Steering Committee member)

Accomplishments

Awards

  • Frank Doyle (‘Gold’) medal for Fellowship of the Royal College of Radiologists (FRCR) exam
  • British Heart Foundation Centre for Research Excellence DPhil Fellowship
  • CCLG Scholarship to attend ESO-SIOPE Masterclass
  • Royal College of Radiologists Cyclotron Trust visiting fellowship
  • Cancer Research UK Programme Grant ‘Benefits and Risks of Cancer Treatment’

Publications

  • Follows GA, Barrington SF, Bhuller KS, Culligan DJ, Cutter DJ, Gallop-Evans E, Kassam S, Osborne W, Sadullah S, Townsend W, Uttenthal BJ, Collins GP. Guideline for the First Line Management of Classical Hodgkin Lymphoma, A British Society for Haematology Guideline. Br J Haematol 2022 Feb 22. Online ahead of print (doi: 10.1111/bjh.18083)
  • Jones DA, Candio P, Shakir R, Ntentas G, Ramroth J, Gray AM, Cutter DJ. Informing Radiotherapy Decisions in Stage I/IIa Hodgkin Lymphoma: Modelling Life Expectancy Using Radiation Dosimetry. Blood Adv 2021 Dec 6. Online ahead of print (DOI: 10.1182/bloodadvances.2021006254)
  • Ntentas G, Dedeckova K, Andrlik M, Aznar MC, Shakir R, Ramroth J, Begum R, Kubeš J, Darby SC, Mikhaeel NG, Cutter DJ. Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection. IJROBP 2021 Nov 9. Online ahead of print (DOI: 10.1016/j.ijrobp.2021.10.151)
  • Cutter DJ, Ramroth J, Diez P, Buckle A, Ntentas G, Popova B, Clifton-Hadley L, Hoskin PJ, Darby SC, Radford J, Illidge T. Predicted Risks of Cardiovascular Disease following Chemotherapy and Radiotherapy in the UK NCRI ‘RAPID’ Trial of PET-directed Therapy for Early-Stage Hodgkin Lymphoma. JCO 2021 Nov 10;39(32):3591-3601
  • Zhang  XY, Collins GP, Cutter DJ, Eyre TA. Limited-stage diffuse large B-cell lymphoma: current management and challenges. Br J Haematol 2021 Aug;194(3):508-517.